Enveric Biosciences receives Nasdaq deficiency notice for failing minimum equity requirement

Enveric Biosciences, Inc.

Nasdaq notified Enveric on Aug 26, 2025 that stockholders' equity of $2.18M as of June 30, 2025 is below $2.5M minimum.
Company has until Oct 10, 2025 to submit a plan to regain compliance; Nasdaq may grant a 180-day extension if plan is accepted.
If plan is rejected, Company may appeal to a Nasdaq Hearings Panel.
Company intends to submit a compliance plan and consider available options to regain compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.